Skip to main content

Lab2Market Discover Radiopharma 2025 Fall

Please contact IP Officer Peter Shao if you are interested in applying

Lab2M Discover Radiopharma (Fall 2025) is a free, 10-week virtual program tailored specifically for researchers in radiopharmaceuticals. It helps participants explore the entrepreneurial potential of their research, transitioning from lab discovery toward market impact.

Apply now.

Description 

Over 10 weeks, you will explore the opportunities and challenges in entrepreneurship as an alternative career path—from the various potential applications of your technology to create a network in the ecosystem.

Delivered in collaboration with the Canadian Centre for Probe Development & Commercialization (CPDC) and led by McMaster University, the program blends instructor-led webinars, curated readings and practical assignments to build entrepreneurial skills tailored to radiopharma. Sessions cover business modeling, customer discovery, IP and pitching—advanced specifically for radiopharmaceutical contexts.

Info Session – Recommended 

Date: August 7, 2025 from noon - 1:00 p.m. EST via Zoom 

Hosted by Program Manager Sydney Valentino 

Register now. 

Program Summary 

Deadlines:

  • Internal Review Deadline (IP Officer): August 22, 2025 by noon EST 
  • L2M Application Deadline: September 3, 2025 by 11:59 p.m. EST  

Funding: Free to participate and no funding provided

Duration: 10 weeks, starting from September 16, 2025 with weekly virtual sessions  

How to Apply:

  1. Consult with IP Officer, Peter Shao to discuss all three internal requirements. 
  2. Submit the online L2M application by September 3, 2025 at 11:59 p.m. EST. 

Contact: Peter Shao (IP Officer) 

Ontario Tech Internal Requirements

All applicants must complete the following three internal requirements before starting their L2M online application. 

  1. Invention Disclosure form – As per the Ontario Tech Intellectual Property Policy, L2M applicants (PI) must disclose to the University the intellectual property they wish to commercialize. You can find a copy of the IP disclosure form at the bottom of the page (see here).
  2. Disclose Conflict of Interest (COI) – To comply with our Conflict of Interest in Research Policy, L2M applications (PI) must disclose to the University any COI.  In the event there is a COI, an approved management plan will be formulated to mitigate the COI.
  3. Enrollment into Brilliant Catalyst – To maximize the benefits of the L2M program, ELs will be required to enroll into the Brilliant Catalyst program to access additional support from the incubator.

L2M Program Eligibility 

  1. Open to current graduate students, recent graduates (MSc/PhD) and postdoctoral researchers at Canadian academic institutions.
  2. Applicants should have active research or interest in radiopharmaceuticals.
  3. Quebec applicants must apply via the QcSE program. 

Program Benefits

This Radiopharma stream is the first of its kind within Lab2Market’s Discover series and serves as an entry point into its broader entrepreneurial pathway (Validate → Launch → Build). The program harnesses CPDC’s radiopharmaceutical expertise and McMaster’s commercialization network to support researchers in moving innovations from the lab to the market.

  • Develop core entrepreneurial skills tailored to radiopharma, including customer discovery, business modeling, intellectual property and pitching.
  • Receive guidance from experienced mentors, including radiopharma professionals from CPDC.
  • Connect with a national innovation network and gain access to McMaster’s and CPDC’s resources.
  • Explore the commercial potential of your research in a supportive, low-risk environment.